// App-Quantinova.ai

EP649 : COMPARISON OF VENETOCLAX INPATIENT AND OUTPATIENT RAMP-UP STRATEGIES FOR CLL. UK MULTICENTRE RESTROSPECTIVE STUDY

Researchers

Presenter

  • Roco Figueroa Mora

Principal Investigators

  • Alexandros Rampotas

  • Daniel Halperin

  • Jennifer Vidler

  • Preston Gavin

  • Moez Dungarwalla

  • Paul Ferguson

  • Nagah Elmusharaf

  • Michelle Furtado

  • Dario Melotti

  • Satyen Gohil

  • Anna Schuh

  • Piers Patten

  • Toby Eyre

  • Nicols Martinez-Calle

  • Tahla Munir

Medical Centers

  • Haematology,Royal Cornwall Hospitals NHS Trust,Cornwall,United Kingdom

  • University Hospitals Leicester NHS Trust, Leicester, United Kingdom

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

  • Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • Cellular Pathology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom

  • Haematology, University College London Hospitals NHS Foundation Trust (UCLH), London, United Kingdom

  • Clinical Haematology,University Hospital North Midlands,Stoke-on-Trent,United Kingdom

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Rheumatology, Oxford University Hospitals NHS Foundation Trust, OXFORD, United Kingdom

  • Haematology,Milton Keynes University Hospital NHS Foundation Trust,Milton Keynes,United Kingdom

  • Haematology,University of Aberdeen,Scotland,United Kingdom

  • Dept. of Haematology, University Hospital of Wales, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Rasburicase

  • Venetoclax

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Dose Escalation

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved